GlassScriptPhysician profile
Vincent J Guzzetta
NPI 1578657482
$3,879.34
in general payments reported to CMS, 2019-2025
36 companies · $394 in 2025
The $394 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $816 · 2020: $275 · 2021: $482 · 2022: $546 · 2023: $591 · 2024: $776 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,760.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $540.97 | 2019-2023 | Xarelto |
| W. L. Gore & Associates, INC. | $395.79 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Musculoskeletal Transplant Foundation INC. | $370.19 | 2019-2022 | |
| Boston Scientific Corporation | $337.37 | 2020-2025 | Enroute Transcarotid Stent, Ranger, Varithena Administration Pack |
| Medtronic, INC. | $295.91 | 2021-2024 | Endurant Iis |
| Inari Medical, INC. | $161.68 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Acera Surgical, INC. | $154.48 | 2024 | Restrata Wound Matrix |
| Endologix LLC | $147.12 | 2023-2024 | Afx2 Bifurcated Endograft System, Ovation Ix Iliac Stent Graft, Alto Abdominal Stent Graft System |
| Tactile Systems Technology INC | $134.06 | 2019-2023 | Entre Plus, Flexitouch Plus |
| Biocompatibles, INC. | $132.74 | 2019 | |
| Cook Medical LLC | $119.52 | 2019 | |
| Bard Peripheral Vascular, INC. | $116.38 | 2019-2023 | Venclose Maven Catheter, Lutonix Drug Coated Balloon |
| Getinge USA Sales, LLC | $103.76 | 2021 | |
| Convatec INC. | $89.30 | 2019-2022 | |
| Silk Road Medical, INC. | $75.56 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $72.24 | 2020-2023 | Alphavac |
| Lemaitre Vascular, INC. | $66.22 | 2019-2025 | Hydro Lemaitre Valvulotome |
| Kerecis Limited | $65.63 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Astrazeneca Pharmaceuticals LP | $64.66 | 2023-2024 | Andexxa |
| E.R. Squibb & Sons, L.L.C. | $63.64 | 2021-2022 | |
| Bolton Medical INC | $44.12 | 2020-2024 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Becton, Dickinson and Company | $41.29 | 2024 | Crosser Iq |
| Aroa Biosurgery Incorporated | $33.60 | 2023 | |
| Baxter Healthcare | $24.16 | 2022 | |
| Biotissue Holdings INC. | $22.54 | 2022 | |
| Cardiva Medical, INC. | $22.51 | 2023 | Cardiva Vascade 6/7f Vcs |
| Ethicon US, LLC | $21.97 | 2023 | Prolene |
| Teleflex LLC | $21.00 | 2021 | |
| Livanova USA, INC. | $20.69 | 2022 | |
| Cardiovascular Systems INC. | $20.12 | 2022 | |
| Pfizer INC. | $18.65 | 2021 | |
| Kci USA, INC. | $18.01 | 2022 | |
| Cardinal Health 200 LLC | $17.32 | 2020 | |
| Abbvie INC. | $17.17 | 2024 | |
| Terumo Medical Corporation | $16.42 | 2022 | |
| Stryker Corporation | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Guzzetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.